We are live on ! Find out more
CRHM

CRH Medical Corporation
CRHM

Delisted

CRHM was delisted on the 22nd of April, 2021.

35 hedge funds and large institutions have $97.9M invested in CRH Medical Corporation in 2019 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 14 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

19% more capital invested

Capital invested by funds: $82.4M → $97.9M (+$15.5M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

10% less funds holding

Funds holding: 3935 (-4)

43% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 14

44% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 9

Holders
35
Holders Change
-4
Holders Change %
-10.26%
% of All Funds
0.76%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
5
Increased
8
Reduced
14
Closed
9
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$18.9M
BGC
2
Beutel, Goodman & Co
Ontario, Canada
$13.8M -$392K -137,010 -3%
SCM
3
Stadium Capital Management
Connecticut
$12.9M +$1.71M +598,591 +16%
Morgan Stanley
4
Morgan Stanley
New York
$7.2M -$1.15M -401,053 -14%
Stifel Financial
5
Stifel Financial
Missouri
$6.67M +$247K +86,336 +4%
PRCP
6
Pacific Ridge Capital Partners
Oregon
$6.4M +$99.2K +34,687 +2%
Connor, Clark & Lunn Investment Management (CC&L)
7
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$6.22M -$213K -74,400 -3%
Canada Pension Plan Investment Board
8
Canada Pension Plan Investment Board
Ontario, Canada
$4.52M
Wellington Management Group
9
Wellington Management Group
Massachusetts
$4.5M +$4.25M +1,486,603 New
Goldman Sachs
10
Goldman Sachs
New York
$4.48M +$1.47M +515,138 +54%
JP Morgan Chase
11
JP Morgan Chase
New York
$3.31M -$196K -68,647 -6%
Deutsche Bank
12
Deutsche Bank
Germany
$3.09M -$378K -131,968 -11%
Renaissance Technologies
13
Renaissance Technologies
New York
$2.03M +$64.4K +22,500 +3%
PP
14
Palladium Partners
Virginia
$630K
D.E. Shaw & Co
15
D.E. Shaw & Co
New York
$582K -$376K -131,300 -40%
UBS Group
16
UBS Group
Switzerland
$561K +$521K +181,969 +5,910%
SCP
17
Seizert Capital Partners
Michigan
$479K -$36.9K -12,905 -8%
RA
18
Royce & Associates
New York
$400K
WCM
19
Wedge Capital Management
North Carolina
$298K -$58.9K -20,603 -17%
TD Asset Management
20
TD Asset Management
Ontario, Canada
$231K -$59.5K -20,815 -21%
QI
21
QS Investors
New York
$182K
WSTAM
22
Wilbanks Smith & Thomas Asset Management
Virginia
$106K
Two Sigma Advisers
23
Two Sigma Advisers
New York
$104K -$343K -119,800 -78%
Northern Trust
24
Northern Trust
Illinois
$91K -$532 -186 -0.6%
CAM
25
Claret Asset Management
Quebec, Canada
$72K -$1.43K -500 -2%

CRHM Hedge Fund Activity: Q2 2019 in Review

35 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in CRH Medical Corporation (CRHM) for Q2 2019, worth a combined $97.9M — up 19% from $82.4M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of CRHM and 5 opened new positions — a net loss of 4 holders — while 14 trimmed existing stakes and 8 added.

The largest buyer was Wellington Management Group, opening a new position worth an estimated $4.25M. The largest seller was Morgan Stanley, cutting an estimated $1.15M.

  • 35 institutional investors held CRH Medical Corporation (CRHM) as of Q2 2019, down from 39 in Q1 2019.
  • Funds reported $97.9M of CRH Medical Corporation stock for Q2 2019, up 19% quarter-over-quarter.
  • 5 funds opened new CRH Medical Corporation positions in Q2 2019 and 9 closed out, a net change of -4 holders.
  • The largest CRH Medical Corporation buyer in Q2 2019 was Wellington Management Group, an estimated $4.25M added.
  • The largest CRH Medical Corporation seller in Q2 2019 was Morgan Stanley, an estimated $1.15M sold.

Based on aggregated 13F filings for Q2 2019.